SCOPE 2019 attracts record attendance with more than 2,000 participants
A Leader in the Clinical Trial Industry: SCOPE Grows by 20% for the fourth consecutive year
SCOPE 2019 at a glance
Celebrating the 10th Annual SCOPE Summit, over 2,000 participants gathered at the Hyatt Regency Orlando, in Orlando, FL, February 18-21, 2019 for 4 days of in-depth discussions covering important issues in clinical trial planning and management.
For four consecutive years SCOPE has grown in attendance by 20%. The 2019 program offered 19 distinct conferences, and 3 plenary keynote sessions, focused on advances and innovative solutions in all aspects of clinical trial management and operations,
including Site Selection and Management, Patient Engagement, Recruitment and Retention, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Sensors, Wearables and Digital Biomarkers, Risk-Based Monitoring, Post-Marketing Studies,
Observational Research, and Clinical Supply Management.
2019 Event Features
- 2,000+ participants
- 19 conferences
- Participant Engagement Awards
- Dedicated Exhibit Hall Hours & Networking Functions
- Interactive Breakout Discussions
- Greater Gift Vaccine Dontations
The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 52% of the attendees titled as a decision maker from leading Pharma (20%), CRO (35%), and Biotech companies (20%). Industry leaders and key
decision makers representing 28 different countries and more than 700 unique organizations shared case studies, collaborated on best practices and provided unique perspectives on poignant issues that the field currently faces.
Hear what people had to say about 2019's event